The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of anlotinib and fulvestrant in patients with HR-positive and HER2-negative, secondary aromatase inhibitor–resistant, metastatic breast cancer.
 
Xiaojia Wang
No Relationships to Disclose
 
Jian Huang
No Relationships to Disclose
 
Wenyan Chen
No Relationships to Disclose
 
Zhengkui Sun
No Relationships to Disclose
 
Jian Liu
No Relationships to Disclose
 
Jiuwei Cui
No Relationships to Disclose
 
Songzhi Wei
No Relationships to Disclose
 
Zheng Lv
No Relationships to Disclose
 
Fan Wu
No Relationships to Disclose
 
Tenghua Yu
No Relationships to Disclose